RXST
RxSight, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.69
+3.99%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$4.46
From 52W high−64.17%
Volume743681.00
Market cap$195.07M
P/E (TTM)—
P/S (TTM)1.5x
Div yield—
Key dataOct 19, 2026
Open
$4.46
From 52W high
−64.17%
Volume
743681.00
Market cap
$195.07M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.1x
P/E (TTM)
—
RSI (14)
39.8
MomentumView details →
1D Return
+3.99%
YTD Return
−55.28%
SummaryUpdated Jun 1, 2026
RxSight, Inc. (NASDAQ:RXST) is a medical technology company founded in 1997 and headquartered in Aliso Viejo, California. Originally incorporated as Calhoun Vision, Inc., the company changed its name to RxSight in February 2017 and went public in July 2021. RxSight has developed and commercialized the world's first and only adjustable intraocular lens technology for cataract surgery, allowing surgeons to customize patients' vision after the initial surgical procedure. The company primarily serves the United States market with plans for international expansion into Europe and Asia.
Similar companies
Latest newsMore news →
K2 Vision reported performing more than 5,000 Light Adjustable Lens procedures and said RxSight, Inc. recognized it as the world's highest-volume Light Adjustable Lens practice.4d agoRxSight, Inc. reported a second-quarter loss of $0.11 per share, beating the Zacks Consensus Estimate of a loss of $0.21, and compared to a loss of $0.08 per share a year ago.75d ago